- Home
- Clinical Trials
Vitiligo Study Dunedin 102
Vitiligo Study
Dunedin
Living with Vitiligo, characterised by white patches on skin, can be hugely challenging and better treatment options are needed for those affected.
Momentum Clinical Research are evaluating the effectiveness of an investigational treatment designed to inhibit the immune response that causes vitiligo patches.
Your participation in this study could not only benefit you but also help make a difference in the lives of others with this condition.
Description
What to expect
Study details
Ages
18 - 75 years old
Duration
The duration of the study is 30 weeks which will include up to 13 scheduled visits to the clinic
Compensation
Participants will be reimbursed up to $5,442
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 to 75 years
- Weigh between 45 and 130 kg
- Have been diagnosed with non-segmental vitiligo for at least 3 months
- Have vitiligo patches on 4% to 50% of the body - This can be assessed by our study doctors for you.
- Have some vitiligo patches on the face.
Additional criteria will be discussed with you.
Locations
Description
Vitiligo is a long-term skin condition characterised by flat white spots or patches on the skin which may start small and enlarge and change shape over time. The hair from the skin may also become white.
Vitiligo is believed to be an autoimmune condition in which the immune system mistakenly attacks and destroys the cells responsible for producing melanin, the pigment that gives skin its colour.
Vitiligo can significantly affect a person's emotional and psychological well-being. The condition is not painful and does not have significant health consequences, but the psychological impact of the changing appearance of the skin can be substantial for those affected.
What to expect
This study is evaluating the effectiveness of an investigational treatment containing an antibody that is delivered intravenously to inhibit the specific immune responses that are involved in the destruction of pigment producing cells.
If you are interested in participating or learning more about the study, please register your details. Your participation could not only benefit you but also help make a difference in the lives of others suffering from this condition.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.